Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice

American Journal of Hypertension

Volumn 16, Issue 10, 2003, Pages 853-858

  Ueda, Atsushi ^a   Ozono, Ryoji ^a   Oshima, Tetsuya ^a   Yano, Ai ^a   Kambe, Masayuki ^a   Teranishi, Yasuhiro ^a   Katsuki, Motoya ^b   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Blood pressure; Dopamine; Knockout; Receptor; Sodium

Indexed keywords

DOPAMINE 2 RECEPTOR; EMONAPRIDE; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CALCULATION; CONTROLLED STUDY; CREATININE URINE LEVEL; DOPAMINERGIC ACTIVITY; FOOD INTAKE; GENE DISRUPTION; HEART RATE; MOUSE; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; SODIUM RETENTION; SODIUM URINE LEVEL; SPECIES COMPARISON; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

EID: 0141786724     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)01013-6     Document Type: Article

References (20)

1. Aperia A: Dopamine action and metabolism in the kidney. Curr Opin Nephrol Hypertens 1994;3:39-45.
2. Jose PA, Eisner GM, Felder RA: Dopaminenergic defect in hypertension. Pediatr Nephrol 1993;7:859-864.
3. Hussain T, Lokhandwala MF: Renal dopamine receptor function in hypertension. Hypertension 1998;32:187-197.
4. Sibley DR, Monsma FJ: Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992;13:61-69.
5. 2 subfamily of dopamine receptor genes in kidney. Am J Physiol 1994;266:F646-F650.
6. 2 receptors. Am J Physiol 1990;259:F924-F928.
7. +-ATPase activity in murine LTK-cells. Mol Pharmacol 1996;49:373-378.
8. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM: Evidence that dopamine-2 mechanisms control renal function. Am J Physiol 1990;259:F793-F800.
9. 2-like receptors on renal function. Am J Physiol 1998;275:R986-R994.
10. 2 plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes Cells 1996;1:253-268.
11. Ozono R, Matsumoto T, Shingu T, Oshima T, Teranishi Y, Kambe M, Matsura H, Kajiyama G, Wang ZQ, Moore AF, Carey RM: Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart. Am J Physiol Regul Integr Comp Physiol 2000;278:R781-R789.
12. Yoshimura M, Komori T, Nishimura M, Habuchi Y, Fujita N, Nakanishi T, Yasumura T, Takahashi H: Diagnostic significance of dopamine estimation using plasma and urine in patients with adrenal and renal insufficiency, renal transplantation and hypertension. Hypertens Res 1995;18:S87-S92.
13. Tyce GM, Van Dyke RA, Rettke SR, Atchison SR, Wiesner RH, Dickson ER, Krom RA: Human liver and conjugation of catecholamines. J Lab Clin Med 1987;109:532-537.
14. 2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmacol 1989;169:61-66.
15. 2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits. J Pharmacol Exp Ther 1992;263:806-815.
16. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM: Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 1989;257:F469-F477.
17. Hansell P, Fasching A: The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int 1991;39:253-258.
18. Williams GHH, Gordon MS, Stuenkel CA, Conlin PR, Hollenberg NK: Dopamine and nonmodulating hypertension. Am J Hypertens 1990;3:112S-115S.
19. 4 receptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocytoma. J Clin Endocrinol Metab 2001;86:4460-4467.
20. 2-like dopamine receptor in rabbit splenic artery. Br J Pharmacol 1998;123:730-736.